• Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review.
  Patel Nirali et al. Journal of neurosurgery. Pediatrics 2023 1-10
• Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.
  Omran Meis et al. Cancer 2023
• How do young people with a hereditary cancer predisposition syndrome understand and experience cancer survivorship?
  Werner-Lin Allison et al. Psycho-oncology 2022
• An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes.
  Schwartz Alison et al. Frontiers in oncology 2022 12942741
• Presentation, diagnosis, and management of the Li-Fraumeni syndrome.
  Ogden John et al. Proceedings (Baylor University. Medical Center) 2022 35(5) 678-679
• Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.
  Rocca Valentina et al. Cancers 2022 14(15)
• Ovarian tumors and genetic predisposition.
  Štellmachová Júlia et al. Ceska gynekologie 2022 87(3) 211-216
• TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes.
  da Silva Paula Francinete Faustino et al. Biomolecules 2022 12(5)
• Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers.
  Sandoval Renata Lazari et al. Frontiers in oncology 2022 12836937
• Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.
  Werner-Lin Allison et al. Social science & medicine (1982) 2022 301114905
• Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit.
  Escudero Adela et al. International journal of clinical oncology 2022
• Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
  Vietri Maria Teresa et al. Genes 2022 13(2)
• Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research.
  Kunst Natalia et al. Journal of the National Cancer Institute 2022
• Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline.
  Kratz Christian Peter et al. Geburtshilfe und Frauenheilkunde 2022 82(1) 42-49
• Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants.
  Schwartz Alison N et al. JCO precision oncology 2022 51677-1686
• Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients.
  Siraj Abdul Khalid et al. Hereditary cancer in clinical practice 2021 19(1) 49
• Inherited TP53 Variants and Risk of Prostate Cancer.
  Maxwell Kara N et al. European urology 2021
• Quantification of Discordant Variant Interpretations in a Large Family-Based Study of Li-Fraumeni Syndrome.
  Frone Megan N et al. JCO precision oncology 2021 5
• Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.
  de Andrade Kelvin César et al. The Lancet. Oncology 2021
• Reproduction and Genetic Responsibility: An Interpretive Description of Reproductive Decision-Making for Young People With Li-Fraumeni Syndrome.
  Forbes Shepherd Rowan et al. Qualitative health research 2021 10497323211046240

More